CDER

FDA
Pharma

FDA official chastises Aurinia med in now-deleted LinkedIn post

In a now-deleted LinkedIn post, the CDER's chief claimed that Lupkynis carries “significant toxicity” despite failing to show direct clinical benefit.
Fraiser Kansteiner Sep 30, 2025 10:15am
stack of letters mail envelopes

FDA targets Big Pharma in deluge of marketing letters

Sep 16, 2025 1:55pm
target reach ladder climb meet win beat competition

FDA taps new CDER chief as acting CBER head after Prasad exit

Jul 30, 2025 1:10pm
FDA

FDA taps George Tidmarsh to lead CDER

Jul 21, 2025 10:53am
FDA

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
FDA Building

FDA's Patrizia Cavazzoni to retire as CDER chief

Jan 10, 2025 10:47am